Janssen Pharmaceuticals (PANCREAZE) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Janssen Pharmaceuticals (PANCREAZE) General Information

Description

A production right related to PANCREAZE capsule. The PANCREAZE capsule is a combination of porcine-derived lipases, proteases and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis and other conditions.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Vivus
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Janssen Pharmaceuticals (PANCREAZE) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Janssen Pharmaceuticals (PANCREAZE)‘s full profile, request access.

Request a free trial

Janssen Pharmaceuticals (PANCREAZE) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Janssen Pharmaceuticals (PANCREAZE)‘s full profile, request access.

Request a free trial

Janssen Pharmaceuticals (PANCREAZE) FAQs

  • Where is Janssen Pharmaceuticals (PANCREAZE) headquartered?

    Janssen Pharmaceuticals (PANCREAZE) is headquartered in .

  • What industry is Janssen Pharmaceuticals (PANCREAZE) in?

    Janssen Pharmaceuticals (PANCREAZE)’s primary industry is Buildings and Property.

  • Is Janssen Pharmaceuticals (PANCREAZE) a private or public company?

    Janssen Pharmaceuticals (PANCREAZE) is a Private company.

  • What is the current valuation of Janssen Pharmaceuticals (PANCREAZE)?

    The current valuation of Janssen Pharmaceuticals (PANCREAZE) is .

  • What is Janssen Pharmaceuticals (PANCREAZE)’s current revenue?

    The current revenue for Janssen Pharmaceuticals (PANCREAZE) is .

  • Who are Janssen Pharmaceuticals (PANCREAZE)’s investors?

    Ortho-McNeil Pharmaceuticals has invested in Janssen Pharmaceuticals (PANCREAZE).

  • When was Janssen Pharmaceuticals (PANCREAZE) acquired?

    Janssen Pharmaceuticals (PANCREAZE) was acquired on 08-Jun-2018.

  • Who acquired Janssen Pharmaceuticals (PANCREAZE)?

    Janssen Pharmaceuticals (PANCREAZE) was acquired by Vivus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process